Outcomes and Comparative Analysis of the Initial Results of Standard Balloon Angioplasty Versus Drug-Coated Balloons Alone Versus in Association With Laser-Excimer Atherectomy in the Treatment of Femoropopliteal Artery In-Stent Restenosis (INTACT).
Eric DucasseMarc SapovalJérôme BrunetPhilippe CommeauYann GouefficJean SabatierEric SteinmetzPatrick LermusiauxEugenio RossetCaroline CaraduPublished in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2024)
This multicenter, prospective, triple-arm randomized, controlled trial focuses on the results of adjunctive therapies, such as excimer laser atherectomy (ELA) and/or drug-coated balloons (DCBs) in the treatment of in-stent restenosis (ISR) in femoropopliteal lesions in 134 patients. It has the originality of being an independent study funded by a grant from the French Ministry of Health. This study confirms a significant decrease in recurrent ISR >70% and increase in primary patency up to 18 months after the use of ELA+DCB and DCBs compared to simple percutaneous transluminal angioplasty in the treatment of femoropopliteal ISR without an increase in major adverse events.
Keyphrases
- randomized controlled trial
- healthcare
- public health
- end stage renal disease
- mental health
- chronic kidney disease
- newly diagnosed
- systematic review
- adipose tissue
- study protocol
- metabolic syndrome
- high resolution
- minimally invasive
- ultrasound guided
- risk assessment
- social media
- health information
- replacement therapy
- meta analyses